Why the study?
Does anticoagulant therapy (heparin and dicumarol) reduce thromboembolic complications and mortality in patients with congestive heart failure?
Population
300 patients with congestive heart failure
Design
Cohort
Follow-up
one year
Authors
Loading...
Anticoagulants were associated with fewer thromboembolic events and lower mortality in heart failure; leaves open need for randomized confirmation before practice change.
Does anticoagulant therapy (heparin and dicumarol) reduce thromboembolic complications and mortality in patients with congestive heart failure?
Levinson et al. (1951) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: